Advances in gene therapy and stem cell research are leading to double-digit annual sales growth in the orthopedic biomaterials market

 
Big growth in biomaterials market (Health Care Finance News)
Ortho device companies expand to boost profits
NEW YORK – Advances in gene therapy and stem cell research are leading to double-digit annual sales growth in the orthopedic biomaterials market, according to the healthcare market research firm Kalorama Information.
In its recently published report, “Orthopedic Biomaterials, the World Market,” New York City-based Kalorama said biomaterials represent 14 percent of the global orthopedics market, or about $5.8 billion in 2010.
“Advances in gene therapy and stem cell research may of...